Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Jubilant Life Sciences gains on its arm entering into stock purchase agreement

23-Nov2017

Jubilant Life Sciences gains on its arm entering into stock purchase agreement

Jubilant Life Sciences is currently trading at Rs. 642.70, up by 5.85 points or 0.92% from its previous closing of Rs. 636.85 on the BSE.

The scrip opened at Rs. 638.40 and has touched a high and low of Rs. 652.00 and Rs. 638.40 respectively. So far 7989 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 879.10 on 12-Apr-2017 and a 52 week low of Rs. 552.40 on 26-Dec-2016.

Last one week high and low of the scrip stood at Rs. 682.00 and Rs. 610.50 respectively. The current market cap of the company is Rs. 10333.36 crore.

The promoters holding in the company stood at 54.02%, while institutions and non-institutions held 24.66% and 21.32% respectively.

Jubilant Life Sciences' a wholly-owned subsidiary -- Drug Discovery and Development Solutions, Singapore (DDDSL) has entered into Stock Purchase Agreement for acquiring entire Equity Share capital of Jubilant Discovery Services Inc., USA (JDSI) on November 21, 2017.

JDSI is a step-down subsidiary whose share capital is held by Jubilant Biosys, a step-down subsidiary of the Company. After the said acquisition of shares, JDSI shall become a wholly-owned subsidiary of DDDSL.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.


Related News

View all news

IndusInd Bank surges on reporting 5% rise in Q2 net profit

IndusInd Bank is currently trading at Rs. 1663.60, up by 36.75 points or 2.26% from its previous closing of Rs. 1626.85 on the BSE.The scrip opened at Rs. 1638.00 and has touched a high and low of Rs.......

Lupin rises with arm partnering with ASHA, NPWH

Lupin is currently trading at Rs. 897.00, up by 16.55 points or 1.88% from its previous closing of Rs. 880.45 on the BSE.The scrip opened at Rs. 889.80 and has touched a high and low of Rs. 910.00 and......

Alembic Pharma surges with receiving USFDA's tentative approval for Alogliptin Tablet

Alembic Pharmaceuticals is currently trading at Rs. 602.35, up by 6.50 points or 1.09% from its previous closing of Rs. 595.85 on the BSE.The scrip opened at Rs. 596.65 and has touched a high and low of......

Top News

View all news

Shalimar Paints lays down foundation of Nashik manufacturing plant

Shalimar Paints has laid down the foundation of a manufacturing unit to be rebuilt in Nashik, in the state of Maharashtra. The company set to commence operations by April 2019 with a planned production......

Delta Corp reports 11% rise in Q2 consolidated net profit

Delta Corp has reported results for second quarter ended September 30, 2018.The company has reported over 2-fold jump in its net profit at Rs 63.51 crore for the quarter under review as compared to Rs......

PNB plans to sell non-core assets worth Rs 8,600 crore during FY19

Punjab National Bank (PNB) has recognized various assets, including its housing finance arm, for sale and hopes to realise Rs 8,600 crore from these non-core assets during the current fiscal. Meanwhile,......